Skip to content

Pacira BioSciences, Inc. PCRX Other Income (Expense)

Other Income (Expense) at other companies

Avanos Medical logo
Avanos MedicalAVNS
0.2%-0.3pp
AtriCure logo
AtriCureATRC
-$37K+79.4%

Segments

By segment

See full
Reportable Segment-$1.9M-128%

Other financials

Income statement

See full
Revenue$177.4M+5.0%
Gross profit$141.0M+4.7%
Operating income$6.9M+247%
Net income$2.9M-39.4%
EPS (diluted)$0.07-30.0%

Balance sheet

See full
Cash & equivalents$144.3M-49.1%
Total debt$411.2M+15.3%
Total equity$653.9M-18.1%
Total assets$1.2B-23.8%

Cash flow

See full
Operating cash flow$25.7M-27.6%
CapEx$2.7M-68.1%
Free cash flow$23.0M-14.7%

Valuation

See full
Market cap$942.78M-16.0%
Enterprise value$1.21B+1.2%
P/E183.5×
P/S1.3×-0.3×

Profitability

See full
Gross margin79.3%+1.7pp
Operating margin3.3%
Net margin0.7%
FCF margin18.1%-4.6pp

Returns & leverage

See full
Return on equity0.7%
Debt / equity0.6×+0.2×
Current ratio4.7×+2.3×

Where this comes from

Reported directly by Pacira BioSciences, Inc. in its filing.

Tagged under the XBRL concept us-gaap:NonoperatingIncomeExpense.

The official record: Pacira BioSciences, Inc.’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Pacira BioSciences, Inc.'s other income (expense).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Pacira BioSciences, Inc.'s other income (expense)?
Pacira BioSciences, Inc. (PCRX) reported other income (expense) of -$1.9M in Q1 2026.
How has Pacira BioSciences, Inc.'s other income (expense) changed year-over-year?
Pacira BioSciences, Inc.'s other income (expense) decreased by 128.4% year-over-year, from $6.72M to -$1.9M.
What is the long-term trend for Pacira BioSciences, Inc.'s other income (expense)?
Over 4 years (2021 to 2025), Pacira BioSciences, Inc.'s other income (expense) has grown at a -48.7% compound annual growth rate (CAGR), from -$33.52M to -$2.32M.
What does other income (expense) mean?
Net total of all non-operating income and expenses not classified in specific line items — a catch-all for miscellaneous financial items.